Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease

Krishna G. Aragam(Massachusetts General Hospital), Pradeep Natarajan(Unknown), Judy H. Cho(Cedars-Sinai Medical Center), Ruth J. F. Loos(Novo Nordisk Foundation), John D. Overton(Yale University), Phoebe Finneran(Harvard University), Amit V. Khera(Broad Institute), Aris Baras(Regeneron (United States)), George Hindy(Regeneron (United States)), Andrew Cagan(Mass General Brigham), Sekar Kathiresan(Massachusetts General Hospital), Amanda Dobbyn(Icahn School of Medicine at Mount Sinai), Renae Judy(University of Pennsylvania), Steven A. Lubitz(Boston Foundation), Kumardeep Chaudhary(Icahn School of Medicine at Mount Sinai), Jordan W. Smoller(Massachusetts General Hospital), Girish N. Nadkarni(Icahn School of Medicine at Mount Sinai), Rachel L. Kember(Mental Illness Research, Education and Clinical Centers), Jeffrey G. Reid(Baylor College of Medicine), Mark Chaffin(Broad Institute), Daniel J. Rader(University of Pennsylvania), Patrick T. Ellinor(Broad Institute), Scott T. Weiss(Outcomes Research Consortium), Ron Do(Icahn School of Medicine at Mount Sinai), Elizabeth W. Karlson(Brigham and Women's Hospital), Lu‐Chen Weng(Broad Institute), Scott M. Damrauer(Philadelphia VA Medical Center), Anthony Philippakis(Google (United States))
Journal of the American College of Cardiology
June 1, 2020
Cited by 146


Related Papers